CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion
Yeon Joo Kim, Won Jun Ji, Jae-Cheol Lee, Sung-Min Chun, Chang-Min Choi
Cancer Research and Treatment. 2022;54(4):985-995.   Published online 2022 January 17    DOI: https://doi.org/10.4143/crt.2021.857

Excel Download

ASSESSMENT OF ANTI-TUMOR EFFICACY OF OSIMERTINIB IN NON-SMALL CELL LUNG CANCER PATIENTS BY LIQUID BIOPSY USING BRONCHOALVEOLAR LAVAGE FLUID, PLASMA, OR PLEURAL EFFUSION
Chest. 2020;157(6):A238   Crossref logo
Link1 Link2

Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion
Cancer Research and Treatment. 2022;54(4):985-995   Crossref logo
Link1 Link2 Link3

P-632 Clinical evaluation of intraoperative pleural lavage cytology andpleural effusion in patients with resected non-small cell lung cancer
Lung Cancer. 2005;49:S285   Crossref logo
Link1 Link2

Bronchoalveolar lavage fluid findings following radiotherapy for non- small cell lung cancer
Lung Cancer. 1994;10(5-6):426   Crossref logo
Link1 Link2

Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
BMC Cancer. 2022;22(1):   Crossref logo
Link1 Link2 Link3

EFFICACY OF 1ST/2ND-GENERATION EGFR-TKIS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC) AND PLEURAL EFFUSION
Respirology. 2017;22:117-117   Crossref logo
Link1 Link2

P3.02b-124 Efficacy of Osimertinib in Patients with Non-Small-Cell Lung Cancer (NSCLC) and Pleural Effusion
Journal of Thoracic Oncology. 2017;12(1):S1269   Crossref logo
Link1 Link2

Plasma and Pleural Fluid Pharmacokinetics of Erlotinib and its Active Metabolite OSI-420 in Patients With Non–Small-Cell Lung Cancer With Pleural Effusion
Clinical Lung Cancer. 2011;12(5):307-312   Crossref logo
Link1 Link2

Prognostic Value of Combined Detection of Serum and Pleural Fluid Tumor Markers in Non-small Cell Lung Cancer With Malignant Pleural Effusion
. 2020;   Crossref logo
Link1 Link2

Prognostic Value of Combined Detection of Serum and Pleural Fluid Tumor Markers in Non-small Cell Lung Cancer With Malignant Pleural Effusion
. 2020;   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.